Trial Outcomes & Findings for Advanced Reperfusion Strategies for Refractory Cardiac Arrest (NCT NCT03880565)

NCT ID: NCT03880565

Last Updated: 2022-03-10

Results Overview

Number of participants who survived to hospital discharge

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

30 participants

Primary outcome timeframe

Approximately 25 days

Results posted on

2022-03-10

Participant Flow

Participant milestones

Participant milestones
Measure
ECMO Facilitated Resuscitation
Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: ECMO is initiated expeditiously, regardless of whether return of spontaneous circulation (ROSC) has been achieved and with on-going mechanical CPR, if required, followed by coronary angiography and percutaneous coronary intervention (PCI) when appropriate. Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: Early use of ECMO
Standard ACLS Resuscitation
Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Patients with refractory VF/VT OHCA will be treated with ACLS resuscitation for at least 15 minutes after arrival in the emergency department (ED), or up to 60 minutes from 911 call, after which the physician (MD) can continue resuscitation efforts until ROSC is achieved or futility has been reached based on their clinical judgment. If the patient has not achieved ROSC during the times mentioned above, the ED MD can declare death when he or she believes that ACLS is futile. If ROSC is present upon arrival or has been achieved anytime during resuscitation in the ED, the patient will be taken to the cardiac catheterization laboratory (CCL) for coronary angiography and PCI and potential VA ECMO or other circulatory support device initiation, as clinically indicated. Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Standard life support resuscitation
Overall Study
STARTED
15
15
Overall Study
COMPLETED
14
15
Overall Study
NOT COMPLETED
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
ECMO Facilitated Resuscitation
Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: ECMO is initiated expeditiously, regardless of whether return of spontaneous circulation (ROSC) has been achieved and with on-going mechanical CPR, if required, followed by coronary angiography and percutaneous coronary intervention (PCI) when appropriate. Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: Early use of ECMO
Standard ACLS Resuscitation
Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Patients with refractory VF/VT OHCA will be treated with ACLS resuscitation for at least 15 minutes after arrival in the emergency department (ED), or up to 60 minutes from 911 call, after which the physician (MD) can continue resuscitation efforts until ROSC is achieved or futility has been reached based on their clinical judgment. If the patient has not achieved ROSC during the times mentioned above, the ED MD can declare death when he or she believes that ACLS is futile. If ROSC is present upon arrival or has been achieved anytime during resuscitation in the ED, the patient will be taken to the cardiac catheterization laboratory (CCL) for coronary angiography and PCI and potential VA ECMO or other circulatory support device initiation, as clinically indicated. Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Standard life support resuscitation
Overall Study
Withdrawal by Subject
1
0

Baseline Characteristics

Advanced Reperfusion Strategies for Refractory Cardiac Arrest

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
ECMO Facilitated Resuscitation
n=15 Participants
Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: ECMO is initiated expeditiously, regardless of whether return of spontaneous circulation (ROSC) has been achieved and with on-going mechanical CPR, if required, followed by coronary angiography and percutaneous coronary intervention (PCI) when appropriate. Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: Early use of ECMO
Standard ACLS Resuscitation
n=15 Participants
Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Patients with refractory VF/VT OHCA will be treated with ACLS resuscitation for at least 15 minutes after arrival in the emergency department (ED), or up to 60 minutes from 911 call, after which the physician (MD) can continue resuscitation efforts until ROSC is achieved or futility has been reached based on their clinical judgment. If the patient has not achieved ROSC during the times mentioned above, the ED MD can declare death when he or she believes that ACLS is futile. If ROSC is present upon arrival or has been achieved anytime during resuscitation in the ED, the patient will be taken to the cardiac catheterization laboratory (CCL) for coronary angiography and PCI and potential VA ECMO or other circulatory support device initiation, as clinically indicated. Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Standard life support resuscitation
Total
n=30 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
n=5 Participants
11 Participants
n=7 Participants
21 Participants
n=5 Participants
Age, Categorical
>=65 years
5 Participants
n=5 Participants
4 Participants
n=7 Participants
9 Participants
n=5 Participants
Age, Continuous
58.8 years
STANDARD_DEVIATION 9.7 • n=5 Participants
57.1 years
STANDARD_DEVIATION 10.6 • n=7 Participants
58.5 years
STANDARD_DEVIATION 10 • n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
4 Participants
n=7 Participants
5 Participants
n=5 Participants
Sex: Female, Male
Male
14 Participants
n=5 Participants
11 Participants
n=7 Participants
25 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
White
6 Participants
n=5 Participants
2 Participants
n=7 Participants
8 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants
n=5 Participants
12 Participants
n=7 Participants
18 Participants
n=5 Participants
Region of Enrollment
United States
15 participants
n=5 Participants
15 participants
n=7 Participants
30 participants
n=5 Participants

PRIMARY outcome

Timeframe: Approximately 25 days

Number of participants who survived to hospital discharge

Outcome measures

Outcome measures
Measure
ECMO Facilitated Resuscitation
n=15 Participants
Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: ECMO is initiated expeditiously, regardless of whether return of spontaneous circulation (ROSC) has been achieved and with on-going mechanical CPR, if required, followed by coronary angiography and percutaneous coronary intervention (PCI) when appropriate. Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: Early use of ECMO
Standard ACLS Resuscitation
n=15 Participants
Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Patients with refractory VF/VT OHCA will be treated with ACLS resuscitation for at least 15 minutes after arrival in the emergency department (ED), or up to 60 minutes from 911 call, after which the physician (MD) can continue resuscitation efforts until ROSC is achieved or futility has been reached based on their clinical judgment. If the patient has not achieved ROSC during the times mentioned above, the ED MD can declare death when he or she believes that ACLS is futile. If ROSC is present upon arrival or has been achieved anytime during resuscitation in the ED, the patient will be taken to the cardiac catheterization laboratory (CCL) for coronary angiography and PCI and potential VA ECMO or other circulatory support device initiation, as clinically indicated. Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Standard life support resuscitation
Survival
6 Participants
1 Participants

SECONDARY outcome

Timeframe: At hospital discharge (average of 25 days), 3 months, 6 months

Population: All participants who completed each time point are included.

mRS scale ranges from 0 (no residual symptoms) to 6 (dead). Scores of 3 (the patient has moderate disability), 2 (the patient has slight disability), 1 (the patient has no significant disability), and 0 indicate favorable outcome. Higher scores on the scale indicate more severe disability. Outcome is reported as the mean score. Outcome is collected and reported at hospital discharge (average of 25 days) and at three and six months following.

Outcome measures

Outcome measures
Measure
ECMO Facilitated Resuscitation
n=15 Participants
Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: ECMO is initiated expeditiously, regardless of whether return of spontaneous circulation (ROSC) has been achieved and with on-going mechanical CPR, if required, followed by coronary angiography and percutaneous coronary intervention (PCI) when appropriate. Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: Early use of ECMO
Standard ACLS Resuscitation
n=15 Participants
Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Patients with refractory VF/VT OHCA will be treated with ACLS resuscitation for at least 15 minutes after arrival in the emergency department (ED), or up to 60 minutes from 911 call, after which the physician (MD) can continue resuscitation efforts until ROSC is achieved or futility has been reached based on their clinical judgment. If the patient has not achieved ROSC during the times mentioned above, the ED MD can declare death when he or she believes that ACLS is futile. If ROSC is present upon arrival or has been achieved anytime during resuscitation in the ED, the patient will be taken to the cardiac catheterization laboratory (CCL) for coronary angiography and PCI and potential VA ECMO or other circulatory support device initiation, as clinically indicated. Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Standard life support resuscitation
Modified Rankin Scale (mRS) Score
Hospital Discharge
3.8 score on a scale
Interval 3.0 to 4.6
5 score on a scale
There is only one participant in this group.
Modified Rankin Scale (mRS) Score
Three Months
2 score on a scale
Interval 0.9 to 3.4
Modified Rankin Scale (mRS) Score
Six Months
1.5 score on a scale
Interval 0.4 to 2.6

SECONDARY outcome

Timeframe: At hospital discharge (average of 25 days), 3 months, 6 months

Population: All participants who completed each time point are included.

CPC scale ranges from 1 (good cerebral performance) to 5 (brain death). CPC scores of 2 (moderate cerebral disability) and 1 indicate functional status. Higher scores on the scale indicate worse cerebral performance. Outcome is reported as the mean score. Outcome is collected and reported at hospital discharge (average of 25 days) and at three and six months following.

Outcome measures

Outcome measures
Measure
ECMO Facilitated Resuscitation
n=15 Participants
Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: ECMO is initiated expeditiously, regardless of whether return of spontaneous circulation (ROSC) has been achieved and with on-going mechanical CPR, if required, followed by coronary angiography and percutaneous coronary intervention (PCI) when appropriate. Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: Early use of ECMO
Standard ACLS Resuscitation
n=15 Participants
Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Patients with refractory VF/VT OHCA will be treated with ACLS resuscitation for at least 15 minutes after arrival in the emergency department (ED), or up to 60 minutes from 911 call, after which the physician (MD) can continue resuscitation efforts until ROSC is achieved or futility has been reached based on their clinical judgment. If the patient has not achieved ROSC during the times mentioned above, the ED MD can declare death when he or she believes that ACLS is futile. If ROSC is present upon arrival or has been achieved anytime during resuscitation in the ED, the patient will be taken to the cardiac catheterization laboratory (CCL) for coronary angiography and PCI and potential VA ECMO or other circulatory support device initiation, as clinically indicated. Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Standard life support resuscitation
Cerebral Performance Categories (CPC) Scale
Hospital Discharge
2.5 score on a scale
Interval 1.9 to 3.1
4 score on a scale
There is only one participant in this group.
Cerebral Performance Categories (CPC) Scale
Three Months
1.2 score on a scale
Interval 0.7 to 1.6
Cerebral Performance Categories (CPC) Scale
Six Months
1.2 score on a scale
Interval 0.7 to 1.6

SECONDARY outcome

Timeframe: 6 months

Population: Outcome was not collected.

Outcome is reported as the mean treatment cost in dollars.

Outcome measures

Outcome data not reported

Adverse Events

ECMO Facilitated Resuscitation

Serious events: 15 serious events
Other events: 0 other events
Deaths: 9 deaths

Standard ACLS Resuscitation

Serious events: 15 serious events
Other events: 0 other events
Deaths: 14 deaths

Serious adverse events

Serious adverse events
Measure
ECMO Facilitated Resuscitation
n=15 participants at risk
Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: ECMO is initiated expeditiously, regardless of whether return of spontaneous circulation (ROSC) has been achieved and with on-going mechanical CPR, if required, followed by coronary angiography and percutaneous coronary intervention (PCI) when appropriate. Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation: Early use of ECMO
Standard ACLS Resuscitation
n=15 participants at risk
Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Patients with refractory VF/VT OHCA will be treated with ACLS resuscitation for at least 15 minutes after arrival in the emergency department (ED), or up to 60 minutes from 911 call, after which the physician (MD) can continue resuscitation efforts until ROSC is achieved or futility has been reached based on their clinical judgment. If the patient has not achieved ROSC during the times mentioned above, the ED MD can declare death when he or she believes that ACLS is futile. If ROSC is present upon arrival or has been achieved anytime during resuscitation in the ED, the patient will be taken to the cardiac catheterization laboratory (CCL) for coronary angiography and PCI and potential VA ECMO or other circulatory support device initiation, as clinically indicated. Standard Advanced Cardiac Life Support (ACLS) Resuscitation: Standard life support resuscitation
Blood and lymphatic system disorders
Bleeding
46.7%
7/15 • Number of events 7 • Six months following hospital discharge
0.00%
0/15 • Six months following hospital discharge
Blood and lymphatic system disorders
Circulatory Disorder
100.0%
15/15 • Number of events 45 • Six months following hospital discharge
100.0%
15/15 • Number of events 20 • Six months following hospital discharge
Nervous system disorders
Central Nervous System Disorders
60.0%
9/15 • Number of events 12 • Six months following hospital discharge
6.7%
1/15 • Number of events 3 • Six months following hospital discharge
Injury, poisoning and procedural complications
CPR Trauma
73.3%
11/15 • Number of events 198 • Six months following hospital discharge
6.7%
1/15 • Number of events 2 • Six months following hospital discharge
Endocrine disorders
Endocrine Disorders
86.7%
13/15 • Number of events 20 • Six months following hospital discharge
66.7%
10/15 • Number of events 12 • Six months following hospital discharge
Gastrointestinal disorders
Gastrointestinal Disorder
60.0%
9/15 • Number of events 10 • Six months following hospital discharge
13.3%
2/15 • Number of events 2 • Six months following hospital discharge
Infections and infestations
Infection
33.3%
5/15 • Number of events 6 • Six months following hospital discharge
0.00%
0/15 • Six months following hospital discharge
Renal and urinary disorders
Kidney Disorders
66.7%
10/15 • Number of events 18 • Six months following hospital discharge
6.7%
1/15 • Number of events 1 • Six months following hospital discharge
Respiratory, thoracic and mediastinal disorders
Respiratory Disorder
86.7%
13/15 • Number of events 19 • Six months following hospital discharge
13.3%
2/15 • Number of events 4 • Six months following hospital discharge
General disorders
Other Disorder
60.0%
9/15 • Number of events 13 • Six months following hospital discharge
13.3%
2/15 • Number of events 3 • Six months following hospital discharge

Other adverse events

Adverse event data not reported

Additional Information

Demetri Yannopoulos, MD

University of Minnesota

Phone: 612-626-2935

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place